Andmed seisuga: 04.10.2022 17:02 (GMT+3)

InMedica 2Y 5% bond (28.06.2022)

Vilnius | First North võlakirjanimekiri

INMB050023FA  |  ISIN LT0000405987

InMedica

InMedica

Name: UAB "InMedica" 
Core business: private healthcare services
Date of registration: 18 March 2004 
Auditor: UAB „Persense Audit“
Date of bond listing (First North, ISIN LT0000404246): 9 March 2020 
Date of bond listing (First North, ISIN LT0000405987): 17 February 2022
Market: Nasdaq Vilnius

Management Board
Nerijus Drobavičius (Chairman), Kęstutis Broniukaitis (Secretary), Ashwin Roy, Josifs Apts, Stella Lapina, Aleksejs Tjurkins

Background Information

“InMedica”, which after the merger with the “MediCA” group now manages the network of 77 clinics, provides diagnostic, outpatient treatment, surgical, dental and other medical services. The “InMedica” group consists of 58 family medicine centres, 6 wide-profile, 7 specialized, 6 walk-in clinics and 3 laboratories.

After the merger, the “InMedica” group now has more than 2800 employees and provides healthcare services to more than 260,000 registered patients. “INVL Baltic Sea Growth Fund”, one of the largest private equity investment funds in the Baltics, owns 45 percent of the shares in the „InMedica“ network through its subsidiary “BSGF Sanus”, 40 percent of the shares is owned by “Repharm”, the largest private medical group in Latvia, and 15 percent – by the company “Litgaja”.

Contact Details 
Address: Ozo g. 12A, LT-08200 Vilnius                    
Telephone/Fax: +370 5 265 1852 
E–mail: info@inmedica.lt
Contact person: Kęstutis Broniukaitis (CEO), +370 5 265 1852

 

Dokumendid

Dokumendid

2020
Märts

Offer Document lt, 2 MB

Kaubeldavad väärtpaberid

Aktsiad
Võlakirjad
Fondid

Turuinfo

Statistika
Kauplemine
Indeksid
Oksjonid

Turureeglid

Reeglid ja hinnad
Järelevalve

Alusta siit

Ettevõttele
Investorile
Liikmetele
First North turu nõustajatele

Uudised

Nasdaqi uudised
Ettevõtete uudised
Kalender

Meist

Ettevõttest
Kontorid